US Stock MarketDetailed Quotes

CHRS Coherus BioSciences

Watchlist
  • 1.610
  • +0.110+7.33%
Close Dec 13 16:00 ET
  • 1.610
  • 0.0000.00%
Post 20:02 ET
185.49MMarket Cap-17.89P/E (TTM)

Coherus BioSciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-14.21%-62.02M
253.50%59.73M
31.96%-46.77M
27.47%-174.88M
87.06%-12.94M
-46.40%-54.3M
22.23%-38.92M
-27.18%-68.73M
-544.17%-241.12M
-91.03%-99.95M
Net income from continuing operations
72.88%-10.75M
69.86%-12.92M
235.85%102.88M
18.46%-237.89M
-35.30%-79.65M
54.25%-39.64M
14.52%-42.87M
21.18%-75.73M
-1.62%-291.75M
-28.75%-58.87M
Operating gains losses
--1.09M
---11.46M
---153.65M
----
----
----
----
----
--6.22M
--0
Depreciation and amortization
72.30%1.55M
34.89%1.19M
58.80%1.51M
2.49%3.79M
1.24%1.06M
-9.65%899K
-0.79%880K
23.73%949K
7.09%3.7M
25.60%1.05M
Other non cash items
20.19%762K
434.43%1.43M
-1,989.15%-2.7M
-92.29%3.39M
123.18%3.31M
-60.13%634K
-126.74%-427K
-100.33%-129K
-69.27%43.96M
24.29%1.48M
Change In working capital
-122.77%-61.53M
1,292.23%74.26M
-21.74%-11.38M
53.54%-36.83M
111.66%6.37M
-417.69%-27.62M
61.60%-6.23M
45.40%-9.35M
-287.10%-79.26M
-165.00%-54.61M
-Change in receivables
110.37%7.81M
292.18%76.64M
0.59%8.58M
-1,254.48%-150.68M
-134.38%-44.06M
-406.97%-75.28M
-3,084.96%-39.88M
42.36%8.53M
-61.68%13.05M
-240.91%-18.8M
-Change in inventory
63.89%-6.94M
45.55%-7.1M
-328.87%-11.46M
1.30%-46.73M
-20.44%-11.79M
17.67%-19.23M
-16.04%-13.04M
9.82%-2.67M
-657.20%-47.35M
-6.56%-9.79M
-Change in prepaid assets
-116.92%-1.65M
-291.79%-2.24M
31.78%5.16M
203.08%18.18M
83.46%3.37M
149.25%9.72M
-84.72%1.17M
153.06%3.92M
-1,058.11%-17.64M
-69.11%1.84M
-Change in payables and accrued expense
-218.84%-67.93M
-77.32%10.33M
35.98%-12.24M
621.21%142.41M
311.21%58.85M
109.62%57.16M
425.95%45.53M
-49.84%-19.12M
-269.98%-27.32M
9.28%-27.86M
-Change in other working capital
--7.18M
---3.36M
---1.42M
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
-14.21%-62.02M
253.50%59.73M
31.96%-46.77M
27.47%-174.88M
87.06%-12.94M
-46.40%-54.3M
22.23%-38.92M
-27.18%-68.73M
-544.17%-241.12M
-91.03%-99.95M
Investing cash flow
Cash flow from continuing investing activities
-99.12%444K
-33.14%27.66M
1,056.93%202.76M
186.69%144.64M
127.10%35.2M
11,160.39%50.55M
4,800.57%41.37M
149.21%17.53M
-20.55%-166.85M
-220.85%-129.9M
Net PPE purchase and sale
----
----
----
127.42%559K
----
----
----
----
-58.18%-2.04M
81.41%-87K
Net business purchase and sale
--0
----
----
--7M
--0
--7M
----
----
--0
--0
Net investment purchase and sale
--0
--0
-14.93%14.89M
208.44%138.14M
128.43%36.21M
--43.4M
--41.03M
--17.5M
-11,263.25%-127.38M
-217.99%-127.38M
Net other investing changes
194.04%444K
-58,972.65%-200.17M
722,496.15%187.88M
97.19%-1.05M
35.45%-1.57M
--151K
--340K
100.07%26K
72.48%-37.43M
---2.43M
Cash from discontinued investing activities
Investing cash flow
-99.12%444K
-33.14%27.66M
1,056.93%202.76M
186.69%144.64M
127.10%35.2M
11,160.39%50.55M
4,800.57%41.37M
149.21%17.53M
-20.55%-166.85M
-220.85%-129.9M
Financing cash flow
Cash flow from continuing financing activities
-101.50%-167K
-445.93%-187.93M
-76.68%887K
28.12%69.6M
-94.45%366K
-77.28%11.11M
7,434.67%54.33M
305.07%3.8M
4.72%54.33M
343.38%6.59M
Net issuance payments of debt
---141K
----
----
--0
--0
--0
----
----
--49.93M
--0
Net common stock issuance
--0
-100.10%-52K
-77.95%1.51M
1,028.00%71.72M
-101.65%-105K
--11.44M
--53.55M
--6.84M
-84.46%6.36M
--6.36M
Proceeds from stock option exercised by employees
--0
-49.30%685K
182.52%291K
-16.87%2.5M
37.38%996K
-32.91%53K
-18.76%1.35M
-81.07%103K
-77.53%3.01M
-57.10%725K
Net other financing activities
93.25%-26K
6,115.42%34.71M
70.93%-911K
7.06%-4.62M
-7.14%-525K
45.08%-385K
38.75%-577K
-10.39%-3.13M
-105.03%-4.97M
-141.38%-490K
Cash from discontinued financing activities
Financing cash flow
-101.50%-167K
-445.93%-187.93M
-76.68%887K
28.12%69.6M
-94.45%366K
-77.28%11.11M
7,434.67%54.33M
305.07%3.8M
4.72%54.33M
343.38%6.59M
Net cash flow
Beginning cash position
117.68%159.69M
1,469.05%260.23M
61.51%103.34M
-84.68%63.99M
-71.90%80.71M
-73.41%73.36M
-94.91%16.59M
-84.68%63.99M
-22.89%417.64M
-20.43%287.25M
Current changes in cash
-939.87%-61.74M
-277.08%-100.54M
430.96%156.88M
111.13%39.36M
110.14%22.63M
-35.07%7.35M
213.11%56.78M
48.20%-47.4M
-185.29%-353.65M
-494.07%-223.26M
End cash Position
21.36%97.95M
117.68%159.69M
1,469.05%260.23M
61.51%103.34M
61.51%103.34M
-71.90%80.71M
-73.41%73.36M
-94.91%16.59M
-84.68%63.99M
-84.68%63.99M
Free cash flow
-14.21%-62.02M
253.50%59.73M
31.96%-46.77M
27.96%-175.17M
86.78%-13.22M
-44.62%-54.3M
23.57%-38.92M
-25.74%-68.73M
-527.99%-243.16M
-89.51%-100.04M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -14.21%-62.02M253.50%59.73M31.96%-46.77M27.47%-174.88M87.06%-12.94M-46.40%-54.3M22.23%-38.92M-27.18%-68.73M-544.17%-241.12M-91.03%-99.95M
Net income from continuing operations 72.88%-10.75M69.86%-12.92M235.85%102.88M18.46%-237.89M-35.30%-79.65M54.25%-39.64M14.52%-42.87M21.18%-75.73M-1.62%-291.75M-28.75%-58.87M
Operating gains losses --1.09M---11.46M---153.65M----------------------6.22M--0
Depreciation and amortization 72.30%1.55M34.89%1.19M58.80%1.51M2.49%3.79M1.24%1.06M-9.65%899K-0.79%880K23.73%949K7.09%3.7M25.60%1.05M
Other non cash items 20.19%762K434.43%1.43M-1,989.15%-2.7M-92.29%3.39M123.18%3.31M-60.13%634K-126.74%-427K-100.33%-129K-69.27%43.96M24.29%1.48M
Change In working capital -122.77%-61.53M1,292.23%74.26M-21.74%-11.38M53.54%-36.83M111.66%6.37M-417.69%-27.62M61.60%-6.23M45.40%-9.35M-287.10%-79.26M-165.00%-54.61M
-Change in receivables 110.37%7.81M292.18%76.64M0.59%8.58M-1,254.48%-150.68M-134.38%-44.06M-406.97%-75.28M-3,084.96%-39.88M42.36%8.53M-61.68%13.05M-240.91%-18.8M
-Change in inventory 63.89%-6.94M45.55%-7.1M-328.87%-11.46M1.30%-46.73M-20.44%-11.79M17.67%-19.23M-16.04%-13.04M9.82%-2.67M-657.20%-47.35M-6.56%-9.79M
-Change in prepaid assets -116.92%-1.65M-291.79%-2.24M31.78%5.16M203.08%18.18M83.46%3.37M149.25%9.72M-84.72%1.17M153.06%3.92M-1,058.11%-17.64M-69.11%1.84M
-Change in payables and accrued expense -218.84%-67.93M-77.32%10.33M35.98%-12.24M621.21%142.41M311.21%58.85M109.62%57.16M425.95%45.53M-49.84%-19.12M-269.98%-27.32M9.28%-27.86M
-Change in other working capital --7.18M---3.36M---1.42M----------------------------
Cash from discontinued investing activities
Operating cash flow -14.21%-62.02M253.50%59.73M31.96%-46.77M27.47%-174.88M87.06%-12.94M-46.40%-54.3M22.23%-38.92M-27.18%-68.73M-544.17%-241.12M-91.03%-99.95M
Investing cash flow
Cash flow from continuing investing activities -99.12%444K-33.14%27.66M1,056.93%202.76M186.69%144.64M127.10%35.2M11,160.39%50.55M4,800.57%41.37M149.21%17.53M-20.55%-166.85M-220.85%-129.9M
Net PPE purchase and sale ------------127.42%559K-----------------58.18%-2.04M81.41%-87K
Net business purchase and sale --0----------7M--0--7M----------0--0
Net investment purchase and sale --0--0-14.93%14.89M208.44%138.14M128.43%36.21M--43.4M--41.03M--17.5M-11,263.25%-127.38M-217.99%-127.38M
Net other investing changes 194.04%444K-58,972.65%-200.17M722,496.15%187.88M97.19%-1.05M35.45%-1.57M--151K--340K100.07%26K72.48%-37.43M---2.43M
Cash from discontinued investing activities
Investing cash flow -99.12%444K-33.14%27.66M1,056.93%202.76M186.69%144.64M127.10%35.2M11,160.39%50.55M4,800.57%41.37M149.21%17.53M-20.55%-166.85M-220.85%-129.9M
Financing cash flow
Cash flow from continuing financing activities -101.50%-167K-445.93%-187.93M-76.68%887K28.12%69.6M-94.45%366K-77.28%11.11M7,434.67%54.33M305.07%3.8M4.72%54.33M343.38%6.59M
Net issuance payments of debt ---141K----------0--0--0----------49.93M--0
Net common stock issuance --0-100.10%-52K-77.95%1.51M1,028.00%71.72M-101.65%-105K--11.44M--53.55M--6.84M-84.46%6.36M--6.36M
Proceeds from stock option exercised by employees --0-49.30%685K182.52%291K-16.87%2.5M37.38%996K-32.91%53K-18.76%1.35M-81.07%103K-77.53%3.01M-57.10%725K
Net other financing activities 93.25%-26K6,115.42%34.71M70.93%-911K7.06%-4.62M-7.14%-525K45.08%-385K38.75%-577K-10.39%-3.13M-105.03%-4.97M-141.38%-490K
Cash from discontinued financing activities
Financing cash flow -101.50%-167K-445.93%-187.93M-76.68%887K28.12%69.6M-94.45%366K-77.28%11.11M7,434.67%54.33M305.07%3.8M4.72%54.33M343.38%6.59M
Net cash flow
Beginning cash position 117.68%159.69M1,469.05%260.23M61.51%103.34M-84.68%63.99M-71.90%80.71M-73.41%73.36M-94.91%16.59M-84.68%63.99M-22.89%417.64M-20.43%287.25M
Current changes in cash -939.87%-61.74M-277.08%-100.54M430.96%156.88M111.13%39.36M110.14%22.63M-35.07%7.35M213.11%56.78M48.20%-47.4M-185.29%-353.65M-494.07%-223.26M
End cash Position 21.36%97.95M117.68%159.69M1,469.05%260.23M61.51%103.34M61.51%103.34M-71.90%80.71M-73.41%73.36M-94.91%16.59M-84.68%63.99M-84.68%63.99M
Free cash flow -14.21%-62.02M253.50%59.73M31.96%-46.77M27.96%-175.17M86.78%-13.22M-44.62%-54.3M23.57%-38.92M-25.74%-68.73M-527.99%-243.16M-89.51%-100.04M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Tesla
TSLA
+4.34%
MicroStrategy
MSTR
+4.20%
MARA Holdings
MARA
+0.66%
Apple
AAPL
+0.07%
Microsoft
MSFT
-0.51%

Unlock the Full List